Cryoprecipitate utilization review in light of recent guidelines: a single-center prospective analysis of haemato-oncology patients
- 8 September 2025
- journal article
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 32 (4) , 341-349
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cryoprecipitate as an alternative to platelet transfusion in thrombocytopeniaeJHaem, 2021
- An overview of thrombotic complications of old and new anticancer drugsThrombosis Research, 2020
- Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac SurgeryJAMA, 2019
- The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseasesThrombosis Research, 2019
- Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: A randomized pilot trialThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Association of Cryoprecipitate and Tranexamic Acid With Improved Survival Following Wartime InjuryJAMA Surgery, 2013
- Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemiaTransfusion and Apheresis Science, 2012
- Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) StudyArchives of Surgery, 2012
- Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemiaLeukemia Research, 2011
- Guidelines on fibrinogen assaysBritish Journal of Haematology, 2003